Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | ANNUAL REPORT | ea0281719-10k_polaryx.htm iXBRL | 10-K | 1489388 |
| 2 | DESCRIPTION OF THE COMPANY'S SECURITIES | ea028171901ex4-2.htm | EX-4.2 | 38641 |
| 3 | ADDENDUM #2 TO CONSULTANCY AGREEMENT, DATED MARCH 23, 2026, BY AND BETWEEN MSTON | ea028171901ex10-13.htm | EX-10.13 | 5507 |
| 4 | INSIDER TRADING POLICY | ea028171901ex19-1.htm | EX-19.1 | 82768 |
| 5 | CERTIFICATION | ea028171901ex31-1.htm | EX-31.1 | 9241 |
| 6 | CERTIFICATION | ea028171901ex31-2.htm | EX-31.2 | 9238 |
| 7 | CERTIFICATION | ea028171901ex32-1.htm | EX-32.1 | 5195 |
| 8 | INCENTIVE COMPENSATION CLAWBACK POLICY | ea028171901ex97-1.htm | EX-97.1 | 25656 |
| 9 | GRAPHIC | ea028171901_img1.jpg | GRAPHIC | 338306 |
| 10 | GRAPHIC | ea028171901_img2.jpg | GRAPHIC | 359369 |
| 11 | GRAPHIC | ea028171901_img3.jpg | GRAPHIC | 226688 |
| 12 | GRAPHIC | ea028171901_img4.jpg | GRAPHIC | 63929 |
| 13 | GRAPHIC | ea028171901_img5.jpg | GRAPHIC | 232152 |
| 14 | GRAPHIC | ea028171901_img6.jpg | GRAPHIC | 227704 |
| 15 | GRAPHIC | ea028171901_img7.jpg | GRAPHIC | 293687 |
| 16 | GRAPHIC | ea028171901_img8.jpg | GRAPHIC | 91303 |
| 17 | GRAPHIC | ea028171901_img9.jpg | GRAPHIC | 214579 |
| 18 | GRAPHIC | ea028171901_img10.jpg | GRAPHIC | 183669 |
| 19 | GRAPHIC | ea028171901_img11.jpg | GRAPHIC | 248331 |
| 20 | GRAPHIC | ea028171901_img12.jpg | GRAPHIC | 366038 |
| 21 | GRAPHIC | ea028171901_img13.jpg | GRAPHIC | 206014 |
| 22 | GRAPHIC | ea028171901_img14.jpg | GRAPHIC | 116058 |
| 23 | GRAPHIC | ea028171901_img15.jpg | GRAPHIC | 671914 |
| 24 | GRAPHIC | ea028171901_img16.jpg | GRAPHIC | 126872 |
| 25 | GRAPHIC | ea028171901_img17.jpg | GRAPHIC | 622330 |
| 26 | GRAPHIC | ea028171901_img18.jpg | GRAPHIC | 191325 |
| 27 | GRAPHIC | ea028171901_img19.jpg | GRAPHIC | 255421 |
| 28 | GRAPHIC | ea028171901_img20.jpg | GRAPHIC | 459993 |
| 29 | GRAPHIC | ea028171901_img21.jpg | GRAPHIC | 461005 |
| 30 | GRAPHIC | ea028171901_img22.jpg | GRAPHIC | 354026 |
| 31 | GRAPHIC | ea028171901_img23.jpg | GRAPHIC | 207055 |
| 32 | GRAPHIC | ea028171901_img24.jpg | GRAPHIC | 385796 |
| 33 | GRAPHIC | ea028171901_img25.jpg | GRAPHIC | 357365 |
| 34 | GRAPHIC | ea028171901_img26.jpg | GRAPHIC | 180640 |
| 35 | GRAPHIC | ea028171901_img27.jpg | GRAPHIC | 160704 |
| 36 | GRAPHIC | ea028171901_img28.jpg | GRAPHIC | 220551 |
| 37 | GRAPHIC | ea028171901_img29.jpg | GRAPHIC | 368625 |
| 38 | GRAPHIC | ea028171901_img30.jpg | GRAPHIC | 292412 |
| 39 | GRAPHIC | ea028171901_img31.jpg | GRAPHIC | 221921 |
| 40 | GRAPHIC | ea028171901_img32.jpg | GRAPHIC | 213235 |
| 41 | GRAPHIC | ea028171901_img33.jpg | GRAPHIC | 211788 |
| 42 | GRAPHIC | ea028171901_img34.jpg | GRAPHIC | 205068 |
| 43 | GRAPHIC | ea028171901_img35.jpg | GRAPHIC | 202748 |
| 44 | GRAPHIC | ea028171901_img36.jpg | GRAPHIC | 171332 |
| 45 | GRAPHIC | ea028171901_img37.jpg | GRAPHIC | 145192 |
| 46 | GRAPHIC | ea028171901_ex19-1img1.jpg | GRAPHIC | 6473 |
| 47 | GRAPHIC | ea028171901_ex97-1img1.jpg | GRAPHIC | 2435 |
| Complete submission text file | 0001213900-26-033064.txt | 30776746 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 48 | XBRL SCHEMA FILE | plyx-20251231.xsd | EX-101.SCH | 35179 |
| 49 | XBRL CALCULATION FILE | plyx-20251231_cal.xml | EX-101.CAL | 29270 |
| 50 | XBRL DEFINITION FILE | plyx-20251231_def.xml | EX-101.DEF | 131072 |
| 51 | XBRL LABEL FILE | plyx-20251231_lab.xml | EX-101.LAB | 301518 |
| 52 | XBRL PRESENTATION FILE | plyx-20251231_pre.xml | EX-101.PRE | 248386 |
| 109 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0281719-10k_polaryx_htm.xml | XML | 398201 |
EIN.: 000000000 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-43080 | Film No.: 26783579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)